Thursday , may 10 ( healthday news ) - - patients ' access to new and better cancer drugs varies widely depending on which country they live in , a new swedish study says 5月10日，星期四， （每日健康新闻） ?一项新的瑞典研究称，癌症患者能否得到更新更好的抗癌药物治疗，根据其所在国不同而有很大差异。
Treatment for colorectal cancer may include surgery , chemotherapy ( use of anti - cancer drugs ) , or radiotherapy ( use of x - rays to target and kill cancer cells ) , alone or in combination 治疗方法结肠直肠癌的治疗方法包括单独或合并使用外科手术、化疗(使用抗癌药物)或放射治疗(利用x光对付或消灭癌细胞) 。
Researchers analyzed data on access to 67 innovative cancer drugs in 25 countries , including australia , canada , japan , new zealand , south africa , the united states , and 19 european nations 研究人员分析了67种新型抗癌药物在25个国家的应用情况资料，这些国家包括澳大利亚、加拿大、日本、新西兰、南非、美国，以及19个欧洲国家。
A randomized phase ii study on combination of gemcitabine plus cisplatin versus gemcitabine plus etoposide was done between 1997 and 1999 on 89 patients with stage iiib or iv nsclc 在1997至1999年间，肿瘤学系使用新的抗癌药物gemcitabine结合cisplatin或etoposide ，进行第二期临床测试，参与测试的有89名nsclc第iiib期或iv期病人。
Since the complex cisplatin was clinically used in cancer chemotherapy in the late 1960s , metal complexes have attracted much attention as a new type of potential anticancer drugs involving dna as the major biological target 尤其是20世纪60年代末顺铂抗癌作用的发展和临床应用，更进一步促进了以dna为靶分子的金属抗癌药物的研究。
In chapter 4 , renewable arnperometric immunosensor based on sol - gel technique has been developed by dispersing graphite , complement 3 antiserum and sol - gel at low temperature for the determination of complement 3 in human serum 这些研究对于新型抗癌药物的设计和肿瘤的化学治疗有指导意义，同时，对于建立简便而有效的抗癌药物筛选方法也良有帮助的。
The study found that austria , france , switzerland and the united states are the leaders in the use of new cancer drugs , while new zealand , poland , the czech republic , south africa and the united kingdom are the slowest to use new cancer drugs 研究发现，在应用新型抗癌药物方面，澳大利亚、法国、瑞士、美国处于领先地位，而新西兰、波兰、捷克、南非及英国最为滞后。
In this thesis , the deposition properties and the release behavior after deposition of a low molecular model drug ( rhodamine b ) and four kinds of anti - cancer drugs ( daunorubicin ( dnr ) , adroamycin ( adm ) , cisplatin and carboplatin ) have been examined 本文还研究了小分子模型药物(罗丹明b ， rdb )和四种抗癌药物(顺铂， cisplatin ；卡铂， carboplatin ；柔红霉素， dnr ；阿霉素， adm )在聚电解质微胶囊中的自发沉积和释放性能。
